1217710-14-9 Usage
General Description
"(S)-2-(2-(trifluoromethyl)phenyl)pyrrolidine" is a chemical compound with the molecular formula C12H13F3N. It is a pyrrolidine derivative with a substituted phenyl group, containing a trifluoromethyl substituent. (S)-2-(2-(TRIFLUOROMETHYL)PHENYL)PYRROLIDINE is a chiral molecule, existing as a single enantiomer, and has a wide range of potential applications in organic synthesis and pharmaceutical research. It is commonly used as a building block in the synthesis of various pharmaceuticals, agrochemicals, and advanced materials due to its unique structural and chemical properties. Additionally, this compound has been studied for its potential biological activity and pharmacological effects, making it a valuable candidate for drug discovery and development.
Check Digit Verification of cas no
The CAS Registry Mumber 1217710-14-9 includes 10 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 7 digits, 1,2,1,7,7,1 and 0 respectively; the second part has 2 digits, 1 and 4 respectively.
Calculate Digit Verification of CAS Registry Number 1217710-14:
(9*1)+(8*2)+(7*1)+(6*7)+(5*7)+(4*1)+(3*0)+(2*1)+(1*4)=119
119 % 10 = 9
So 1217710-14-9 is a valid CAS Registry Number.
1217710-14-9Relevant articles and documents
Bcl-2 INHIBITORS
-
Paragraph 0219; 0220, (2019/11/19)
Disclosed herein is a compound of Formula (I) for inhibiting Bcl-2 and treating disease associated with undesirable bcl-2 activity (Bcl-2 related diseases), a method of using the compounds disclosed herein for treating dysregulated apoptotic diseases including cancers and treating autoimmune disease, and a pharmaceutical composition comprising the same.
COMPOUNDS AND COMPOSITIONS AS TRK INHIBITORS
-
Page/Page column 99, (2012/09/11)
The invention provides compounds, pharmaceutical compositions comprising such compounds and methods of using such compounds to treat or prevent diseases or disorders associated with abnormal or deregulated TRK kinase activity.
